Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

A combined 4D ultrasound, hysteroscopic cold-knife plowing, uterine stent, and traditional Chinese medicine approach for intrauterine adhesions

Official title: Investigating the Association Between Diagnostic and Therapeutic Management Models and Prognosis of Intrauterine Adhesions Based on a Large-Scale Prospective Cohort Study

Run by The Third Xiangya Hospital of Central South University · NCT07421908 · Data updated 2026-11-12

This project will try a combined care pathway—preoperative 4D ultrasound, hysteroscopic cold-knife adhesion separation, a postoperative uterine stent, and traditional Chinese medicine—to see if it improves outcomes for women aged 18–45 with intrauterine adhesions.

More Intrauterine Adhesion trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment5000 (estimated)
SponsorThe Third Xiangya Hospital of Central South University
Academic / other
Locations1 site (Changsha, Hunan)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedMarch 1, 2030
Study endsMarch 1, 2035
Registry record updatedFebruary 19, 2026
Trial IDNCT07421908 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–45 diagnosed with intrauterine adhesions at the participating centers who can comply with diagnosis, treatment, and follow-up are ideal candidates.

Probably not a fit

Patients with abnormal ovarian function, primary male-factor infertility, or who cannot adhere to treatment and follow-up schedules are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter real-world cohort enrolling up to 5,000 cases (2,000 at the lead center) of women aged 18–45 treated for intrauterine adhesions. Patients receive preoperative four-dimensional color ultrasound, intraoperative integrated hysteroscopy with cold-knife plowing for immediate adhesion separation, placement of a patented uterine cavity stent to prevent re-adhesion, and postoperative traditional Chinese medicine prescriptions to promote endometrial repair. Follow-up uses 4D ultrasound combined with intraoperative AI gland-density counts and multimodal data fusion to build a postoperative infertility risk prediction model and track pregnancy outcomes. The study aims to test feasibility and real-world effectiveness of the full management model across participating centers.

Why it matters

Potential benefit: If successful, the combined pathway could reduce adhesion recurrence, improve endometrial recovery and pregnancy outcomes, and reduce the need for repeat hysteroscopies.

How similar studies have gone: Components such as hysteroscopic adhesiolysis and uterine stents have mixed evidence and traditional Chinese medicine has variable support, while the integrated model with cold-knife plowing, 4D ultrasound follow-up, and AI gland-density analysis is novel and not yet proven in large cohorts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with intrauterine adhesions diagnosed and treated in our hospital and the sub-central units of this project: aged 18-45 years old; The collection began after the ethical review was passed. A total of 5,000 cases were collected, and 2,000 cases were collected in this center.

Exclusion Criteria:

* Abnormal ovarian function, male infertility, inability to cooperate with diagnosis and treatment and follow-up visits

Where it's running

  • The Third Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.